Hangzhou Converd Co., Ltd.

This early study tests a new treatment called hV01, a virus modified to attack cancer cells and boost the immune system. It is for people with advanced pancreatic cancer that has not responded to standard treatments. The goal is to see if the virus can shrink tumors and control t…

This early study tests a new combination therapy for people with advanced solid tumors that have stopped responding to standard treatments. The therapy uses a modified virus (hV01) designed to infect and kill cancer cells while boosting the immune system, plus an immunotherapy dr…